Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Spatial biology bridges the gap between cell phenotyping and tissue imaging by using high-plex approaches to unlock exciting possibilities for advances in immuno-oncology and beyond. This includes amongst others:
- Deep phenotyping
- Biomarker research and discovery
- Drug target discovery and validation
In this webinar, we will show you how we identified and evaluated novel target candidates for the cellular immunotherapy of pancreatic ductal adenocarcinoma. We dissected the expression of more than 100 markers on tumor cells at single-cell resolution and investigated CAR-T cell infiltration into tumors.
We will also present the MACSima™ Imaging Platform in detail. This platform provides the perfectly orchestrated combination of a fully automated instrument, specifically designed sample carriers, a broad portfolio of pre-tested antibodies, and a tailor-made and powerful image analysis software. This reduces the time needed to obtain ready-to-publish data to a minimum.
- Analyze the localization of proteomic markers in intact tissue sections
- Discover how an advanced imaging platform provides an entire workflow solution for spatial biology
- Identify and evaluate novel target candidates for cellular immunotherapy
Jenia Schlegel, PhD
Spatial Biology & Imaging, Miltenyi Biotec
Dr. Jenia Schlegel joined Miltenyi Biotec as a Global Product Manager for Spatial Biology Imaging at the end of 2021. She is responsible for the MACSima™ Imaging Platform, including disposables and buffers. Dr. Schlegel received her PhD in developmental biology from the Heinrich Heine University Düsseldorf, Germany in 2021. Prior, she did her bachelor and master studies at the Goethe University in Frankfurt (Main), Germany in Biophysics and Cell Biology and Physiology, respectively. In 2017, she spent seven months as a doctoral researcher at Michigan State University, East Lansing, MI, USA.
Sara Rahmati, PhD
Spatial Biology & Imaging, Miltenyi Biotec
Dr. Sara Rahmati joined Miltenyi Biotec in October 2022 as Global Product Manager for Spatial Biology Imaging and is responsible for the MACSima Imaging Platform, focused on the instrument. She earned her bachelor’s degree in Iran and her master's in Germany both in physics. Before joining Miltenyi Biotec, Dr. Rahmati received her PhD in Bio-imaging at Bordeaux University, France in 2022 where she gained deep knowledge of a diverse range of imaging technologies and 3D in vitro neuronal models.